Industry Providers Related News

Oxford Genetics Licenses SnapFast™ Expression Vectors to Twist Bioscience

November 16, 2017, Oxford, England and San Francisco, Calif. – Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, announced today a new licensing agreement with Twist Bioscience Corporation, a company enabling customers to [...]

By | November 16th, 2017|DNA Synthesis, Industry Providers, News|

SnapGene and Synbio Technologies Partner to Streamline Construct Design and Synthesis

SnapGene customers can now order synthetic biology constructs directly from the software through Synbio Technologies. November 13, 2017 10:00 AM Eastern Standard Time CHICAGO--(BUSINESS WIRE)--Synbio Technologies and GSL Biotech have finalized a non-exclusive agreement allowing customers of GSL Biotech’s “SnapGene” software to [...]

By | November 14th, 2017|CAD Tools, DNA Synthesis, Industry Providers, News|

Synbio Technologies to be First DNA Manufacturer Listed on National Equities Exchange and Quotation (NEEQ)

On November   7th 2017, Synbio Technologies is excited to be publicly listed on the NEEQ and we are eager to observe the benefits this listing brings.  With this public listing, Synbio Technologies has become the first DNA manufacturing company to [...]

By | November 12th, 2017|DNA Synthesis, Industry Providers, News, Press Releases|

Zymergen Announces Expansion With New Office in Seattle

Molecular Technology Company Opens Hub for Software Engineers and Data Scientists November 03, 2017 10:00 AM Eastern Daylight Time EMERYVILLE, Calif.--(BUSINESS WIRE)--Zymergen, a molecular technology company ushering in a new age of manufacturing and industrial innovation, today announced the opening [...]

By | November 7th, 2017|News, Organism Engineering Platforms, Press Releases|

Frost & Sullivan Commends Sphere Fluidics for Its Innovative Single-cell Analysis Platform Solution

Sphere Fluidics’ Cyto-Mine® solution outperforms traditional technologies by performing sorting, imaging, and dispensing in a single platform SANTA CLARA, Calif. — October 31, 2017 — Based on its recent analysis of the single cell analysis industry, Frost & Sullivan recognizes [...]

Arcturus Therapeutics and Synthetic Genomics Announce Strategic Alliance to Develop Next-Generation Vaccines and Therapeutics

San Diego, Calif., October 31, 2017 – Arcturus Therapeutics, Inc., a leading RNA medicines company, and Synthetic Genomics, Inc. announced today that they have entered into a research collaboration and worldwide license agreement to develop self-amplifying RNA-based vaccines and therapeutics in [...]